Starting treatment: Ethnicity Māori patients (3.5-fold higher) and 272 pmp among Pacific patients The incidence of renal replacement higher). In 2013, the ratios were therapy remained substantially higher 4.4 among Māori and 5.5 among among Māori and Pacific patients Pacific patients (Figure 3.5). than among NZ European patients. There is considerable disparity in the This inequity in entering end-stage opportunity to commence treatment kidney disease treatment remains with a kidney transplant (pre-emptive persistent and marked (Figure 3.5). transplantation) based on ethnicity. The incidence of renal replacement Of the 24 patients who received a therapy has been stable (62-76 pmp) kidney transplant, none in among New Zealand European and 2015 identified as Māori, 1 was Asian Asian New Zealand patients, whereas (2.2%) and 2 (1.9%) identified as the incidence is 216 pmp among Pacific ethnicity (Figure 3.6).
Starting treatment: Ethnicity The incidence of renal replacement therapy remained substantially higher among Māori and Pacific patients than among NZ European patients. This inequity in entering end-stage kidney disease treatment remains persistent and marked (Figure 3.5). The incidence of renal replacement therapy has been stable (62-76 pmp) among New Zealand European and Asian New Zealand patients, whereas the incidence is 216 pmp among Māori patients (3.5-fold higher) and 272 pmp among Pacific patients higher). In 2013, the ratios were 4.4 among Māori and 5.5 among Pacific patients (Figure 3.5). There is considerable disparity in the opportunity to commence treatment with a kidney transplant (pre-emptive transplantation) based on ethnicity. Of the 24 patients who received a kidney transplant, none in 2015 identified as Māori, 1 was Asian (2.2%) and 2 (1.9%) identified as Pacific ethnicity (Figure 3.6).
nz-care-processes-and-treatment-targets-report-2015.docx